Soleus Capital Management, L.P. - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 2 filers reported holding HARPOON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$722,000
+41.0%
42,472
+37.5%
0.38%
+31.2%
Q2 2020$512,000
-90.6%
30,886
-93.4%
0.29%
-95.4%
Q1 2020$5,453,000
+199.3%
470,926
+282.2%
6.34%
+261.1%
Q4 2019$1,822,000123,2001.76%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 3,156,699$2,335,9571.93%
MPM ASSET MANAGEMENT LLC 3,131,388$2,329,7530.97%
MPM BioImpact LLC 3,196,707$2,378,3500.62%
Lion Point Capital, LP 169,283$125,9800.05%
Artal Group S.A. 1,000,000$7440.04%
Cormorant Asset Management, LP 540,600$4020.03%
KENNEDY CAPITAL MANAGEMENT LLC 529,934$394,3770.01%
Orbimed Advisors 621,218$462,3100.01%
Tekla Capital Management LLC 259,910$193,4250.01%
CM WEALTH ADVISORS LLC 50,354$290.01%
View complete list of HARPOON THERAPEUTICS INC shareholders